(5-BROMO-2-CHLOROPHENYL)(4-ETHOXYPHENYL)METHANONE,
461432-22-4,
Methanone, (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)-,
5-bromo-2-chloro-4'-ethoxybenzophenone,
AK-45003,
Dapagliflozin Impurity 6,
PubChem19264,
Dapagliflozin Intermediate I,
SCHEMBL17019,
(5-bromo-2-chloro-phenyl)-(4-ethoxyphenyl)methanone,
MET048,
CTK4I9196,
DTXSID30434334,
OEURLNJEQCLGPS-UHFFFAOYSA-N,
AMX10147,
BCP09251,
CS-B0022,
ZX-AH056802,
ANW-59625,
MFCD11044417,
RW4002,
ZINC34094196,
AKOS009476100,
AN-2438,
CB-3261,
QC-2694,
ABA-9376417,
AC-27004,
ACM461432224,
AJ-86929,
BC004429,
BC249411,
DS-13458,
SC-28419,
AX8046107,
DB-011718,
TC-148370,
4CH-021635,
AM20090706,
FT-0654424,
ST24034800,
Z6157,
432B224,
(5-bromo-2-chloro phenyl)(4-ethoxyphenyl)methanone,
(5-BroMo-2-chlorophenyl)(4-ethoxyphenyl) Methanone,
(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)-methanone,
S14-1635,
Methanone,(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)-,
C15H12BrClO2,
ACN-037229,
CS-O-31934,
CID10020105,
A7212,
5-BROMO-2-CHLOROPHENYL 4-ETHOXYPHENYL KETONE,